BGICC 2019

Blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-NHL

Alpha/beta T-cell and B-cell depletion haplo-HSCT is an effective treatment for children with acute leukaemia

Daratumumab increases PFS in patients with transplant-ineligible multiple myeloma

Daratumumab found to increase PFS in patients with transplant-ineligible newly diagnosed multiple myeloma

Myeloma XI study: Quadruplet regimen for transplant eligible patients

The benefits of a stem cell transplant after CAR T-cell therapy in paediatric patients

ACT-1: Addition of alemtuzumab to a CHOP backbone for young patients with T-cell lymphoma

Diversity of gut microbiota linked with complications from haematopoietic cell transplantation

Ibrutinib alone and in combination with rituximab for older patients with chronic lymphocytic leukaemia

Stem cell transplant after CAR T-cell therapy reduces relapses in acute lymphocytic leukaemia

Latest analysis of the ELIANA trial for acute lymphocytic leukaemia